Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma

CompletedOBSERVATIONAL
Enrollment

599

Participants

Timeline

Start Date

July 5, 2015

Primary Completion Date

August 18, 2023

Study Completion Date

August 18, 2023

Conditions
Glioblastoma
Interventions
PROCEDURE

Blood drawl

Trial Locations (27)

1011

Centre Hospitalier Universitaire Vaudois - Lausanne, Lausanne

1070

Hopitaux Universitaires Bordet-Erasme, Brussels

1090

Universitaetsklinikum Wien - AKH uniklinieken, Vienna

6000

CHU de Nice - Hopital Pasteur, Nice

8091

Univ. Spital Zurich, Zurich

10126

Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Giovanni, Torino

13385

Hopitaux de Marseille - Hôpital de La Timone (APHM), Marseille

34298

Institut du Cancer de Montpellier, Montpellier

35128

Azienda Ospedaliera Di Padova - Istituto Oncologico Veneto IRCCS, Padua

45147

Universitaetsklinikum - Essen, Essen

53105

Universitaetsklinikum Bonn, Bonn

60528

Ronellenfitsch Michael, Frankfurt

69120

UniversitaetsKlinikum Heidelberg, Heidelberg

69677

CHU Lyon - Hopital neurologique Pierre Wertheimer, Bron

75475

Hopitaux de Paris - Hopital Saint-Louis, Paris

75651

Hopitaux de Paris - La Pitie Salpetriere, Paris

79106

Universitaetsklinikum Freiburg, Freiburg im Breisgau

80480

CHU d'Amiens - CHU Amiens - Hopital Sud, Salouël

81377

Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern, München

81675

Technische Universitaet Muenchen - Klinikum Rechts Der Isar, München

93053

Universitaetsklinikum Regensburg, Regensburg

02115-5450

Dana-Farber Cancer Institute & Harvard Medical School, Boston

Unknown

CHRU de Lille, Lille

01307

Universitaetsklinikum Carl Gustav Carus, Dresden

151 23

Hygeia Hospital, Athens

1081HV

Amsterdam UMC - locatie VUmc, Amsterdam

3015 GD

Erasmus MC, Rotterdam

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT03770468 - Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma | Biotech Hunter | Biotech Hunter